Vitruvias Therapeutics' Series A Round

Vitruvias Therapeutics raised a round of funding on January 05, 2018.

Vitruvias Therapeutics is a start-up generic pharmaceutical company that will focus on developing niche topical generic products that are sold only by prescription. Vitruvias has identified several ni…

Articles about Vitruvias Therapeutics' Series A Round: